On October 11th local time, the US FDA approved Pfizer's drug Hympavzi (marstalimab) for routine prevention or reduction of bleeding in adult and pediatric patients aged 12 and above with hemophilia ...

[The first batch of Novo Nordisk ultra long-acting insulin in the world is expected to be within two months] A few days ago, the Commission on Human Medicines (CHMP) of the European Drug Administrati ...